Evidence map›Paper›PMID 26084862›Full record

ArticleAnnals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc2016

Evaluating the Efficacy and Safety of Internal Cardioversion with Implantable Cardioverter Defibrillator Device for Atrial Fibrillation in Systolic Heart Failure Patients.

Hamza Sunman, Kudret Aytemir, Hikmet Yorgun, Uğur Canpolat, Muhammet Ulvi Yalçin, Naresh Maharjan, Serkan Asil, Levent Şahiner, Barış Kaya, Necla Özer and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 2 pooled it
0.8field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 2 syntheses or guidelines pooled it, 10 citations in OpenAlex.

  1. External versus internal cardioversion for atrial fibrillation: a meta-analysis of randomized controlled trials.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2021
    Pooled it
  2. Pooled it
  3. Review
  4. Nonpharmacological Treatment of Atrial Fibrillation: What Is the Role of Device Therapy?The International journal of angiology : official publication of the International College of Angiology, Inc · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Hamza SunmanDepartment of Cardiology, Ministry of Health Dışkapı Yıldırım Beyazıt Education and Research Hospital, Ankara, Turkey.
Kudret AytemirDepartment of Cardiology, Hacettepe University Faculty of Medicine, Sıhhıye, Ankara, Turkey.
Hikmet YorgunDepartment of Cardiology, Hacettepe University Faculty of Medicine, Sıhhıye, Ankara, Turkey.
Uğur CanpolatDepartment of Cardiology, Türkiye Yüksek İhtisas Hospital, Ankara, Turkey.
Muhammet Ulvi YalçinDepartment of Cardiology, Hacettepe University Faculty of Medicine, Sıhhıye, Ankara, Turkey.
Naresh MaharjanDepartment of Cardiology, Hacettepe University Faculty of Medicine, Sıhhıye, Ankara, Turkey.
Serkan AsilDepartment of Cardiology, Hacettepe University Faculty of Medicine, Sıhhıye, Ankara, Turkey.
Levent ŞahinerDepartment of Cardiology, Hacettepe University Faculty of Medicine, Sıhhıye, Ankara, Turkey.
Barış KayaDepartment of Cardiology, Hacettepe University Faculty of Medicine, Sıhhıye, Ankara, Turkey.
Necla ÖzerDepartment of Cardiology, Hacettepe University Faculty of Medicine, Sıhhıye, Ankara, Turkey.
Ali OtoDepartment of Cardiology, Hacettepe University Faculty of Medicine, Sıhhıye, Ankara, Turkey.
Hacettepe University · TRMinistry of Health · TRTürkiye Yüksek İhtisas Hastanesi · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAtrial fibrillation (AF) commonly observed in patients with heart failure and cardioversion was often needed to restore the sinus rhythm. Previously, there is no study evaluating usefulness of internal cardioversion with implantable cardioverter defibrillator (ICD) device. In this study, we aimed to compare the efficacy and long-term effects of internal cardioversion with ICD devices compared to conventional external cardioversion in patients with AF and heart failure.

methodsSeventy patients with AF and heart failure who underwent electrical cardioversion were enrolled in the study. Forty patients (mean age 65.36 ± 10.37, 35 male) were assigned to undergo internal cardioversion with approximately 35 J shocks delivered through the ICD electrode. Standard external cardioversion was performed for the remaining patients (30 patients; mean age 66.20 ± 11.89; 24 male) that were similar with regard to baseline, and electrocardiographic characteristics.

resultsSinus rhythm was restored in 32 of 40 patients (80.0%) assigned to internal cardioversion compared with 25 of 30 patients (83.3%) assigned to external cardioversion (P = 0.725). We did not witness any serious complication during the procedure and hospitalization. On the follow-up, there was no statistically significant difference in recurrence of AF and incidence of major cardiovascular events between the internal and external cardioversion groups.

conclusionsInternal cardioversion with ICD device is an effective and safe method to restore sinus rhythm in heart failure patients with AF.

Indexed as

Defibrillators, ImplantableAgedAtrial FibrillationElectric CountershockFemaleFollow-Up StudiesHeart Failure, SystolicHumansMaleMiddle AgedTreatment Outcomeatrial fibrillationheart failureinternal cardioversion

Identifiers

PMID26084862
PMCPMC6931764
OpenAlexW2131308248

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.